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Abstract
Glycosaminoglycans (GAGs) interact with many proteins to regulate processes such as
hemostasis, cell adhesion, growth and differentiation, and viral infection. Yet, majority of these
interactions remain poorly understood at a molecular level. A major reason for this state is the
phenomenal structural diversity of GAGs, which has precluded analysis of specificity of their
interactions. We had earlier presented a computational protocol for predicting ‘high specificity’ GAG
sequences based on combinatorial virtual library screening (CVLS) technology. In this work, we expand
the robustness of this technology through rigorous studies of parameters affecting GAG recognition of
proteins, especially antithrombin and thrombin. The CVLS approach involves automated construction of a
virtual library of all possible oligosaccharide sequences (di- to octa- saccharide) followed by a two-step
selection strategy consisting of ‘affinity’ (GOLD score) and ‘specificity’ (consistency of binding) filters.
We find that ‘specificity’ features are optimally evaluated using 100 genetic algorithm experiments,
100,000 evolutions and variable docking radius from 10 Å (disaccharide) to 14 Å (hexasaccharide). The
results highlight critical interactions in H/HS oligosaccharides that govern specificity. Application of
CVLS technology to the antithrombin–heparin system indicates that the minimal ‘specificity’ element is
the GlcAp(14)GlcNp2S3S disaccharide of heparin. The CVLS technology affords a simple, intuitive
framework for the design of longer GAG sequences that can exhibit high ‘specificity’ without resorting to
exhaustive screening of millions of theoretical sequences.
Keywords: Glycosaminoglycans, Heparin/Heparan sulfate, Molecular docking, Specificity, Virtual
screening
Abbreviations used: 3-D, three-dimension(al); AT, antithrombin; GAG, glycosaminoglycan; GlcAp,
glucuronic acid; GlcNp, glucosamine; HS, heparan sulfate; H, heparin; IdoAp, iduronic acid; Nonreducing end, NRE; PDB, Brookhaven Protein Data Bank; RMSD, root mean square difference; SPL,
SYBYL Programming Language; UAp, uronic acid

Introduction
Glycosaminoglycans (GAGs) interact with numerous proteins to regulate various physiological
and pathological processes such as hemostasis, cell adhesion, growth factor signaling, coagulation, viral
pathogenesis, and protease regulation (Capila and Linhardt 2002; Gandhi and Mancera 2008). Heparin
(H) and heparan sulfate (HS), members of the GAG superfamily, are composed of alternating 14-linked
glucosamine (GlcNp) and uronic acid (UAp) residues (either glucuronic (GlcAp) or iduronic (IdoAp))
that are incompletely modified through sulfation, acetylation and epimerization reactions (Shriver et al.
2012). These modifications can produce 48 distinct disaccharides, of which 23 have been found in nature
to date (Esko and Selleck 2002). Further, the IdoAp residue can exist in multiple conformations,
especially 1C4 and 2SO (Mulloy and Forster 2000), that can inter-convert easily in solution to enhance
structural possibilities. Thus, combinatorial arrangements of the several configurational and
conformational variations possible at the monosaccharide level generate millions of distinct H/HS
sequences. Although this massive library of natural H/HS sequences offers a major advantage for
enhancing the probability of protein recognition, it also presents difficulties in deciphering detailed
structure–function relationships for these interesting biopolymers.
A majority of GAG sequences bind to proteins through non-specific interactions because
practically any collection of positive charges on a protein surface tends to recognize a sulfated GAG
chain. Interactions that rely only on electrostatics, e.g., Coulombic, operate over longer distance than
those that rely on hydrogen bond or van der Waals forces.1 This implies that unless a GAG sequence
forms multiple hydrogen bonding or equivalent interactions, the protein–GAG system will exhibit poor
specificity. In fact, not many GAG sequences exhibit characteristics of high specificity. The prototypic
high affinity, high specificity GAG sequence is the heparin pentasaccharide sequence DEFGH (Figure
1A), which contains several key sulfate groups including a 3-O-sulfate on the central GlcNp residue, that
recognizes antithrombin (AT) (Desai et al. 1998; Jin et al. 1997). Other sequences likely to exhibit high
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Coulomb forces have a r-1 relationship (r = distance between two ions), whereas van der Waals forces have a r -3 to
r dependence.
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specificity include a heparin octasaccharide binding to glycoprotein gD of herpes simplex virus-1
(Copeland et al. 2008) and a dermatan sulfate hexasaccharide binding to heparin cofactor II (Maimone
and Tollefsen 1990; Raghuraman et al. 2010). Several other GAG sequences may exhibit specificity of
protein recognition (Capila and Linhardt 2002; Gandhi and Mancera 2008) and are awaiting rigorous
characterization.
Biochemical and/or biological studies based on gene knock-outs of biosynthetic enzymes support
the contention that should be many specific, or selective, GAG sequences within the millions present
naturally to induce the biological changes in a spatiotemporal manner (Esko and Selleck 2002). Yet,
obtaining a library of thousands of homogenous, synthetic GAG sequences is difficult, which precludes
rigorous identification of sequences that exhibit high specificity. Likewise, a large library (e.g., >10,000)
of homogenous sequences using biosynthetic enzymes has not been developed as yet and microarraybased identification of specific sequences from the mixture of GAG isolates from nature requires much
further development.
Under these conditions, computational library screening approaches (Raghuraman et al. 2006,
2010; Agostini et al. 2014) offer considerable promise for identifying sequences that exhibit high
specificity. The rapid increase in computational power has enabled simultaneous screening of GAG
sequences so as to afford detailed understanding of structure–function relationships. Yet, modeling GAGs
is also fraught with challenges. The computational power is still not sufficient to address the entire
theoretical conformational search space of GAGs. For example, a simple, unsulfated H/HS disaccharide
(GlcAp(14)GlcNp) possesses 11 rotatable bonds, which may require a study of up to 1017 bond
rotations2 to understand conformational energetics. For sulfated disaccharides (and higher oligomers), the
conformational search space is much larger. Another fundamental challenge is the difficulty of
computationally parsing the rare specific GAG interactions from the horde of non-specific interactions.
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Assuming that conformational energetics are calculated every 10, 36 rotations will have to be analyzed for every
rotatable bond. For the unsulfated disaccharide containing 11 rotatable bonds, 3611 = 1.321017 rotations must be
analyzed to understand the entire conformational space.

The primary contributory factor to this state is the surface exposure of GAG binding sites on proteins that
induces a primarily electrostatic recognition (Desai 2013).
Despite these difficulties, several computational approaches have been presented in the literature.
For example, standard molecular dynamics and docking were used to deduce the pentasaccharide binding
site on antithrombin (Grootenhuis and van Boeckel 1991, Bitomsky and Wade 1999). More recently,
Agostini et al. (2014) have presented a study of different docking protocols in mapping the binding
geometry of GAGs on several proteins. Likewise, we have presented an algorithm that attempted to
identify ‘high affinity, high specificity’ GAG sequences based on two tandem, logical filters including 1)
the GOLD score (the ‘affinity’ filter) and 2) consistency of binding (the ‘specificity’ filter) (Raghuraman
et al. 2006, 2010). The dual-filter strategy rapidly sorted a small library of H/HS hexasaccharide
sequences binding to AT into ‘specific’ and ‘non-specific’ sequences. Yet, this first-generation approach
was limited in scope. Herein, we expand the robustness of our GOLD-based combinatorial virtual library
screening (CVLS) algorithm by establishing a set of parameters necessary for identification of ‘high
specificity’ sequences, if any, from a haystack of more than 100,000 GAG sequences. Our modified
CVLS approach can be readily applied to all possible H/HS sequences ranging from disaccharide to
hexasaccharide, irrespective of the number of rotatable bonds. Interestingly, our new CVLS protocol
identifies that the minimal sequence capable of recognizing AT with high specificity is the
GlcAp(14)GlcNp2S3S disaccharide (or alternatively the ‘EF’ disaccharide), which is much smaller
than that identified through synthetically prepared tri- and penta- saccharide variants (Desai et al. 1998).
Finally, the new CVLS algorithm affords for the first time a rational framework for designing longer
H/HS sequences that bind AT with high specificity without resorting to exhaustive screening of all
possible sequences.

Methods
Software. SYBYLX 1.3 (Tripos Associates, St. Louis, MO) was used for molecular visualization,
minimization and for preparation of protein structures from the Protein Data Bank. GOLD, v5.1 (Jones et

al. 1997) was used for molecular docking experiments. GAG sequences were built combinatorially in an
automated manner using in-house SPL (SYBYL Programming Language) scripts.
GAG Library Generation. The first step in the CVLS approach is the generation of two libraries (Figure
2). Starting from either a UAp or a GlcNp at the non-reducing end (NRE), so as to give either a UANRE or
GlcNNRE library, respectively, appropriate number of GlcAp (in 4C1 ring pucker), IdoAp (in either 1C4 or
2

SO), and GlcNp (in 4C1) residues were added in a combinatorial manner to generate each library of

desired chain length (di-, tetra-, hexa- or octa- saccharide). The co-ordinates for the two libraries were
generated in an automated fashion with a series of SPL scripts and a set of 38 naturally occurring,
disaccharide building blocks belonging to each of the UAp-GlcNp (Figure 1B) and GlcNp-UAp (Figure
1C) series (Esko and Selleck 2002). Herein, the different monosaccharide units are substituted with either
N-acetyl, N-sulfate or O-sulfate groups (Mulloy and Forster 2000), which gives rise to unique sequences.
To name each unique H/HS sequence, the symbolic representation employed in the GLYCAM (Kirschner
et al. 2008) designation was used. Briefly, the letter ‘Z’ was used for GlcAp, ‘u’ for IdoAp and ‘Y’ for
GlcNp. Similarly, ring conformations were encoded as ‘a’ for 1C4, ‘b’ for 4C1 and ‘c’ for 2SO
conformations (Cremer and Pople 1975; Forster and Mulloy 1993; Rao et al. 1998). Substituents on rings
were represented as ‘H’ (for unsubstituted 2-position), ‘C’ (for N-acetyl), ‘2’ (for N- or O-sulfate), ‘3’ (for
3-O-sulfate) and ‘6’ (for 6-O-sulfate). Anomeric carbon configuration was encoded as ‘A’ for α and ‘B’
for β. This monosaccharide nomenclature is also shown in Table 1. Analysis of the available crystal
structures showed that the inter-glycosidic torsions H (O5-C1-O1-C4’) and H (C1-O1-C4’-C5’) fall
within a relatively narrow range and are essentially invariant irrespective of the substitution pattern (Jin et
al. 1997; Johnson et al. 2006; McCoy et al. 2003; Pol-Fachin and Verli 2008). Thus, average bond
torsions, shown in Table 2, were used for inter-glycosidic linkages. The disaccharide building blocks
were then used to build the desired library using an SPL script following which each sequence was
minimized, as described below, in an automated manner. Thus, the two UANRE and GlcNNRE libraries
contained a total of 2× (38×38×38) = 109,744 unique H/HS hexasaccharide sequences. Likewise, the diand tetra- saccharide libraries consisted of 76 and 2,888 unique sequences, respectively.

Preparation of AT and GAG Sequences for Docking. The coordinates for the activated form of AT
were extracted from the crystal structure of the ternary AT-pentasaccharide-thrombin complex (PDB
entry 1TB6) (Li et al. 2004). Likewise, thrombin coordinates were extracted from both the 1TB6 structure
as well as 1XMN structure (chains A and B) (Carter et al. 2005). Hydrogen atoms were added in SYBYL
X1.3 and the structure minimized with fixed heavy-atom co-ordinates using the Tripos forcefield for a
maximum of 5,000 iterations subject to a termination gradient of 0.05 kcal/(mol·Å). Energy minimization
of the modeled GAG, AT and thrombin structures was performed using the Tripos forcefield with
Gasteiger-Hückel charges, a fixed dielectric constant of 80 and a non-bonded cutoff radius of 8 Å.
Docking of the GAG Sequences. Molecular docking of the library of sequences onto the activated form
of AT was performed using GOLD v.5.1 (Jones et al. 1997). GOLD is a "soft docking" method that
implicitly handles local protein flexibility by allowing a small degree of interpenetration, or van der
Waals overlap, of ligand and protein atoms. GOLD also optimizes the positions of hydrogen-bond
donating atoms on Ser, Thr, Tyr, Lys, and Arg residues as part of the docking process. The binding site in
AT was defined to cover key heparin binding residues including Lys11, Arg13, Arg46, Arg47, Trp49,
Lys114, Phe121, Lys125, Arg129 and Arg132 (Desai 2005; Jin et al. 1997; Pike et al. 2005). Similarly,
the binding site in thrombin was defined to encompass basic residues of exosite 2 including Arg93,
Arg101, Arg126, Arg165, Arg233, Lys236 and Lys240. The grid center was defined as the center of the
enclosure containing these residues.
For the GAG sequences, the inter-glycosidic bonds were constrained. In addition to the two
libraries for each chain length, docking was also performed for the heparin pentasaccharide sequence
(Figure 1A) using the set of optimized parameters. GOLD starts with a population of 100 arbitrarily
docked ligand orientations, evaluates them using a scoring function (the GA “fitness” function) and
improves their average “fitness” by an iterative optimization procedure that is biased towards high scores.
As the initial population is selected at random, several such GA runs are required to more reliably predict
correct bound conformations. The optimized parameters included 100 GA runs for each sequence docked
onto a binding site of 5–16 Å radius, depending upon chain length and number of rotatable bonds, using a

maximum of 100,000 iterations that are continuously evaluated by the GOLD score and/or RMSD
between top ranked solutions. Collectively, these 100 GA runs form one docking experiment from which
the top two solutions were considered for further analysis. Experiments were minimally performed in
triplicate, which would yield at least 6 solutions. To enhance efficiency, the GA was set to pre-terminate
if the top two ranked solutions were within 2.5 Å RMSD. A one or two-step docking protocol was
utilized depending on the library size, as described in Figure 2. If the library contained less than 500
sequences, the analysis relied only on the RMSD between the top six ranked solutions obtained in three
independent experiments for every sequence. If the number of sequences was much higher than 500, a
two-step protocol involving selection of the most promising sequences based on their GOLD scores (the
‘affinity’ filter) followed by re-docking of the selected sequences and evaluation of RMSD between the
top-ranked solutions (the ‘specificity’ filter). Docking was driven by 𝐺𝑂𝐿𝐷𝑆𝑐𝑜𝑟𝑒 = 𝐻𝐵𝐸𝑋𝑇 + 1.375 ×
𝑉𝐷𝑊𝐸𝑋𝑇 equation (HBEXT and VDWEXT are the non-bonded intermolecular hydrogen bond and van der
Waals terms, respectively) to prioritize different poses, as reported earlier (Raghuraman et al. 2006).

Results and Discussion
Development of a robust CVLS approach for identifying ‘high-specificity’ sequences  Our
previous CVLS protocol could be applied to a small library of H/HS sequences (~7,000 sequences) and
screened a limited domain of 3-D space to assess ‘specificity’ of binding (Raghuraman et al. 2006).
However, the repertoire of nature’s sequences is huge, of which the majority are never studied rigorously.
Thus, a more robust CVLS protocol that can be optimally applied to a larger H/HS library is desirable.
Considering the dramatic increase in conformational and configurational space with the size of the
library, it was important to define the optimal parameter set that ensures reproducible and accurate
outcome. Hence, we selected a representative group of 65 H/HS hexasaccharide sequences using the
following rationale. Fifteen hexasaccharide sequences contained the DEF structure, which is known to be
the key high specificity element of the DEFGH pentasaccharide. This group was identified as GDEF.
Likewise, 15 hexasaccharide sequences were selected to contain either the EFG or the FGH structure.

These were identified as GEFG and GFGH groups. The GFGH group was expected to be the most non-specific
group based on literature reports (Desai et al. 1998). Two additional groups of 10 library members each
were constructed to assess specificity elements. The GUSU group contained fewer sulfate groups than the
GDEF group, while the GSSS contained more sulfate groups (see Supplementary data, Table S1).
Because the size of the library in this limited study was small (<500 members), we utilized the
one-step CVLS protocol (see Figure 2) to assess how well a particular sequence binds to AT in multiple
docking runs. A low RMSD (< 2.50 Å) between multiple interaction poses in a GA-based3 search
suggests high consistency of binding. When only a few sequences present in a library display such high
consistency of binding, it suggests specific binding with the protein. In contrast, sequences that bind with
poor consistency (RMSD > 2.50 Å) possess no structural features that uniquely recognize the target and
hence are likely to be non-specific. Thus, based on the literature (Desai et al. 1998; Capila and Linhardt
2002; Raghuraman et al. 2006), the GDEF group should exhibit the highest proportion of sequences that
display RMSD < 2.5 Å (high specificity), while the GFGH and GUSU group should exhibit relatively poor
specificity. These predictions allowed a rigorous assessment of CVLS parameters that impact the
robustness of the protocol including the number of GA runs (10 or 100) and the size of docking radius.
Figure 3 shows CVLS results for the five groups of H/HS hexasaccharide sequences. For each
group, the proportion of sequences displaying RMSD < 2.5 Å was found to be highest at 14 Å and 100
GA runs. More importantly, GDEF displayed higher proportion ‘specific’ sequences, as expected. In
contrast, the ‘non-specific’ group GFGH displayed much lower proportion mirroring biochemical results
(Desai et al. 1998). The GUSU group displayed the least specificity, as one would expect based on the
absence of key sulfate groups.
Interestingly, a 16 Å radius failed to reliably identify ‘specific’ sequences. This was an unusual
result considering that search with 14 Å radius identifies majority of sequences. Most probably, the
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The GA-based approach incorporates domain swaps and mutations so as to screen essentially the entire 3-D space
for each sequence. In other words, a GA-based run attempts to dock a H/HS sequence onto the binding site with all
possible conformations/configurations so as to identify the most optimal fit. This enhances the probability of
identifying interactions arising from key structural features on the H/HS sequence.

failure of 16 Å radius search arises from incomplete conformational search imposed by the limitation in
the maximum number of GA iterations (100,000) used in this study. It is well established that an increase
in docking radius dramatically increases the conformational search space, which in turn requires orders of
magnitude increase in the number of GA iterations. At the other extreme, the reason why searches with 8
and 10 Å radii failed is most likely due to the size of the binding site becoming too small for
hexasaccharide sequences at these radii. With regard to the number of GA iterations, the results show that
10,000 runs appear to not reliably perform a thorough search of the 3-D space. We did not screen an order
of magnitude increase in GA iterations, i.e., 1,000,000 runs, because it would be time-wise not feasible. In
combination, the results for hexasaccharide sequences show that an arbitrary choice of docking
parameters may not yield optimal results within the allocated time frame or make take inexorbitant time
to complete. Thus, GAG docking experiments should be approached with measured steps.
Inference of structure on specificity of recognition  The above study also led to two key advances
with regard to H/HS – AT interaction. 1) It is generally assumed that high sulfation level of a GAG chain
ensures protein binding. This arises from the non-directional nature of electrostatic forces, which favor
recognition of practically any collection of basic residues. In direct contrast to this assumption, the GSSS
group, which comprises of sequences that are more sulfated on average than the GDEF group (see
Supplementary Material, Table S1), displays very few ‘specific’ sequences (Figure 3). In fact, this
proportion is even lower than that for GFGH, which is known to be non-specific in solution, and just
slightly better than that for GUSU. Clearly, for high specificity GAG–protein systems hyper sulfation
destroys specificity of interaction. 2) The GEFG group has not been studied well in the literature, except for
tetrasaccharide EFGH (Desai et al. 1998; Petitou et al. 1997). The CVLS results show that GEFG group
displays the highest proportion of sequences with RMSD <2.5 Å. This proportion is even higher than that
for GDEF suggesting that the EFG trisaccharide of the DEFGH sequence may be a better cause of specific
recognition of AT. This aspect is further addressed below.

Application of the CVLS protocol to a large H/HS library  Can the above more robust CVLS
protocol reliably identify specific sequences from a large library? To address this question, a
combinatorial library of H/HS hexasaccharide sequences was generated from all possible monosaccharide
residues found in nature (Figures 1B and 1C, Table 1), except for the rare free GlcNp. As in our earlier
study, the library considered the conformational flexibility of IdoAp residues in an explicit manner
through the inclusion of both the 1C4 and 2SO conformations and utilized the ‘average backbone’ geometry
of the inter-glycosidic bonds (Raghuraman et al. 2006). Yet, a significant advance over the earlier study
was the explicit consideration of sequences with two different NREs. This led to two libraries, named as
UANRE and GlcNNRE libraries, which were treated independently for computational purposes (Figure 2).
Considering that AT binding is sequence specific, the UANRE and GlcNNRE libraries may yield different
results. Each library contained 54,872 distinct hexasaccharide sequences made combinatorially from 38
disaccharide building blocks, which were generated in a fully automated manner.
The CVLS protocol for the larger library consisted of two steps. The first step involved docking
each of the more than 100,000 hexasaccharides onto AT using the parameters developed above and
analyzing the poses using GOLDScore (see Methods). The highest ranking 54 sequences (or top 0.1%)
from each library were re-docked in three independent runs and the top two poses of each run were
utilized for assessing consistency of binding. The RMSD between the six poses of every sequence was
calculated and sequences displaying values less than 2.5 Å were identified as most promising from the
perspective of specificity. This analytical approach eliminates the need for a reference co-crystal
structure, which may not be possible for many GAG–protein systems, and thus, greatly expands the
applicability of CVLS protocol.
Our CVLS protocol affords deduction of binding specificity from both biological and chemical
considerations. Biological specificity refers to a unique mode of interaction in the binding site among
many possible modes, whereas chemical specificity refers to a unique ligand sequence among the many
sequences available. Because the CVLS protocol operates on a large library and attempts to identify
‘needles in a haystack’, the final identified GAG sequences capture features of chemical specificity.

Likewise, the GA-based identification on one binding mode binding (i.e., low RMSD value) from among
many likely captures features of biological specificity. Yet, the CVLS protocol cannot be expected to
capture all the chemical and biological specificity features of a GAG–protein system in few sequences
because the GAG conformational search space is enormous. However, the dual filter protocol greatly
enhances the probability of rapidly and accurately identifying ‘specific’ GAG sequences.
Of the 54 sequences identified from each of the UANRE and GlcNNRE hexasaccharide libraries
following the 1st filter, 10 and 24 sequences, respectively, satisfied the 2nd filter (Table 3). These poses
were then compared with the pentasaccharide DEFGH geometry of the co-crystal structure (Li et al.
2004) and found to be essentially identical (not shown). Further, the hydrogen bonding analysis using
LIGPLOT (Wallace et al. 1995) showed that the sequences identified by CVLS bound to AT in a manner
similar to DEFGH. The 34 sequences represent a significant increase in identification of specific
sequences from the ten such sequences identified in our earlier work from a library of 6859 (Raghuraman
et al., 2006). This highlights the enhanced robustness of the new algorithm. More importantly, ua2AYbCA-ua2A-YbCA-uaA-Yb26A, or alternatively IdoAp2S-GlcNp2Ac-IdoAp2S-GlcNp2Ac-IdoApGlcNp2S6S, a false negative hexasaccharide identified in our first attempt, was effectively eliminated by
in this more careful protocol.
A comparison of the binding geometry of the 10 and 24 sequences from the UANRE and GlcNNRE
libraries reveals an interesting insight. Although each sequence is distinct, the binding poses attempt to
satisfy a core group of interactions arising from the D, E and F residues. This induces a shift in frame of
one residue between UANRE and GlcNNRE sequences (Figure 4). This also explains why more high
specificity sequences were identified from the GlcNNRE library in comparison to the UANRE library. The
difference in frame between the two libraries affords interactions with the extended heparin-binding site
residues for the GlcNNRE library, which are not realized by sequences of the UANRE library (Figure 4B and
Table 3). These additional interactions contribute to the specificity of binding.
Importance of appropriate restriction of conformational search space  The results with
hexasaccharide sequences indicated that CVLS does not work well with too large a conformational search

space, as demonstrated by an optimal docking radius of 14 Å. We reasoned that presumably this would
hold true for oligosaccharides with other lengths too. Thus, we docked tetrasaccharide sequences
containing the DEF structure onto AT using docking radius ranging from 8 to 16 Å under otherwise
identical conditions. Theoretically, each tetrasaccharide sequence should bind with a low RMSD because
of the presence of the DEF scaffold. Yet, the results revealed that consistent docking was best obtained
with a radius of 12 Å (Figure 5). For disaccharides, we studied all 78 sequences and found that a docking
radius of 10 Å was most optimal. Thus, the results highlight the importance of selecting appropriate
docking radius, which is surrogate for restricting conformational search space, for identifying ‘needles in
a haystack’. For H/HS sequences, it appears that di-, tetra- and hexa- saccharide sequences are best
studied by using docking radius of 10, 12 and 14 Å, respectively.
CVLS predicts the ‘minimal’ H/HS sequence that exhibits high specificity for AT  Although
pentasaccharide DEFGH (Figure 1A) is recognized as the minimal AT specific sequence, detailed
biochemical study with pentasaccharide variants led to the conclusion that trisaccharide DEF was
minimally needed (Desai et al. 1998). The development of the current more robust CVLS protocol
presented an opportunity to assess this computationally using the libraries of tetrasaccharide (2,888
sequence), disaccharide (76 sequences) and monosaccharides (15 sequences). The results showed that 14
UANRE and 16 GlcNNRE tetrasaccharide sequences (see Supplementary Material, Figure S1) and 3 UANRE
(and none GlcNNRE) disaccharide sequences satisfied the RMSD filter (Figure 6). Each of the three
disaccharide sequences contained the GlcAp(14)GlcNp2S3S structure (the EF disaccharide, see Table
S3), which was also present in the high specificity 30 tetrasaccharides (see Table S2) identified from the
library of 2888 sequences. Reducing the size further to monosaccharides eliminated interaction specificity
completely. Likewise, neither the GlcNp6S(14)GlcAp sequence nor the GlcNp2S3S(14)GlcAp
sequence, i.e., neither the DE nor the FE sequence, satisfied the consistency of binding filter (Figure 6B).
The results suggested that the exquisite specificity features displayed by the H/HS–AT system arises from
the EF disaccharide motif.

The abovededuction, in fact, has experimental support. Our detailed studies using stopped flow
fluorimetry (Desai et al. 1998) on a group of variants of pentasaccharide DEFGH have shown that
removal of residue D (as in tetrasaccharide EFGH) or residues G & H (as in trisaccharide DEF) does not
affect specificity of AT recognition. But elimination of residues D and E (as in trisaccharide FGH)
resulted in complete loss in specificity. Thus, key elements of specific recognition of antithrombin are
actually resident in the disaccharide sequence EF. Thus, these CVLS studies significantly advance
understanding on the structural basis of specificity with regard to the antithrombin–heparin system.
Although disaccharide sequence EF may be all that is necessary for specific recognition of AT,
this does not imply residues D, G and H of pentasaccharide DEFGH are not important. This work shows
that if the EF sequence is not present, then the sequence(s) display(s) multiple modes of binding (i.e., lack
biological specificity). The function of D, G and H residues is to contribute binding energy. This is the
reason why pentasaccharide DEFGH sequence is a better pharmaceutical agent than tetrasaccharide
EFGH or trisaccharide FGH.
A simple CVLS-based algorithm for designing longer H/HS sequences  Considering that many
proteins bind longer GAG sequences (Capila and Linhardt 2002; Gandhi and Mancera 2008), we sought
to assess the application of our CVLS approach to the design of H/HS sequence(s) longer than
hexasaccharide. Yet, designing longer sequences de novo is considerably more challenging. For example,
a de novo library of octasaccharide sequences built from the 38 natural disaccharide building blocks
would consist of 384, or 2,085,136, unique sequences for each of the two libraries, UANRE and GlcNNRE.
Exhaustive screening at this scale is not possible in a reasonable timeframe with current computational
power. Hence, we developed a reductionist approach. We reasoned that the 3-D space on either side of the
most specific hexasaccharide sequence(s) could be explored using our CVLS protocol to derive the most
optimal octasaccharide sequence(s).
To test this design algorithm, the docked poses of the five best ranked hexasaccharide sequences
from the UANRE library, which satisfied the dual filters, were selected and 38 disaccharide blocks were
combinatorially attached to either the NRE or the RE to derive two octasaccharide libraries of 190

sequences each (Figure 7A). Likewise, the same procedure was applied to the five best GlcNNRE
hexasaccharide sequences to prepare two libraries of 190 sequences each containing disaccharide
extensions at either the NRE or the RE. The octasaccharide sequences were built in an automated manner,
their ring conformations and inter-glycosidic torsions assessed for consistency, and then sequences
docked onto AT using the dual filter CVLS protocol described in Figure 2. Following the application of
the first filter, the 10 best ranked sequences of the 190 were selected for the consistency of binding
analysis.
Although each sequence in these four libraries contained the DEFGH sequence, which is
theoretically expected to bind to AT with 100% efficiency, the CVLS results suggest a striking preference
for the type of library. No octasaccharide sequence satisfied the ‘specificity’ filter for UANRE and GlcNNRE
libraries to which disaccharides were added at the RE and NRE, respectively. In contrast, six and ten
octasaccharide sequences passed the consistency of binding filter from the UANRE and GlcNNRE libraries
possessing disaccharides at the NRE and RE, respectively (Figure 7B and Table 4). The docked poses
indicate that longer H/HS sequences possess additional interactions with residues of the extended heparin
binding site of AT, especially Arg132. More importantly, the results reveal for the first time the exact
order of residues flanking DEFGH that contribute to AT binding and specificity (see Table 4).
The computational results also provide structural basis for biochemical studies observed earlier
by Huntington and coworkers (2000). In their work, extension of the DEFGH sequence at the RE end was
found to induce a frameshift in binding. We find that extension at the NR end induced a shift in the frame
of hexasaccharide sequences by one residue (see Figure S2). This frameshift arises from a better
interaction of the sequence with AT, which measurably enhances the binding affinity. Also in a recent
study, an octasaccharide sequence with two 3-O-sulfated GlcNp residues was reported to induce higher
affinity to AT in comparison to pentasaccharide DEFGH (Guerrini et al. 2013). Our CVLS studies
identify nine such sequences (see Table 4)as the most optimal and specific octasaccharide sequences.
Thus, the success of the CVLS algorithm implies that this approach could be used to design
longer H/HS sequences one disaccharide block at a time. This is the first simple and intuitive approach to

computationally design longer GAG sequences. The approach obviates extensive library screening and
may be termed as incremental neighborhood optimization strategy.
Application of the CVLS protocol to identify key heparin sequences binding to thrombin  To
assess the applicability of the CVLS approach to proteins other than AT, we studied the thrombin –
heparin system. Thrombin is a key protease of the blood coagulation cascade and widely recognized as
interacting with heparin in a non-specific manner (Olson et al. 1991; Mosier et al. 2012). Heparin binds to
thrombin in anion-binding exosite 2 (Carter et al. 2005). A crystal structure of heparin–thrombin complex
has been reported (‘1XMN’ (Carter et al. 2005)), which presents two different modes of the common
heparin hexasaccharide within exosite 2 alluding to the non-specific nature of interaction.
Each biochemical study performed to date with the thrombin – heparin system has relied either on
the most common heparin sequence, i.e., (IdoAp2S-GlcNp2S6S)3, or on a mixture of unfractionated
heparin sequences. We reasoned that because our CVLS approach affords a rigorous study of each
sequence, it would be better suited to assess whether there are pockets of specificity in thrombin – heparin
system. Thus, the optimized CVLS approach was applied to thrombin using the library of more than
50,000 hexasaccharide sequences. Application of the ‘affinity’ filter led to identification of the best 54
sequences (top 0.1%), which were re-docked to assess the consistency of binding. Only one sequence
satisfied the 2nd filter (Table 5). The pose of this sequence (IdoAp2S-GlcNp2S6S-IdoAp2S-GlcNp2SIdoAp-GlcNp2S3S6S) was compared with that of the sequence present in the crystal structure of the cocomplex and found to be essentially identical (Figure 8A). Thus, the CVLS technology was able to
predict the binding geometry of a GAG sequence onto thrombin. It is instructive to note that only one
sequence out of the more than 50,000 satisfied the ‘specificity’ filter, perhaps supporting the idea that
nearly all heparin sequences can interact with thrombin in more than one unique mode.
To assess these results further, we applied CVLS technology to the 1TB6 thrombin structure (Li
et al. 2004). This structure presents thrombin in a ternary complex with AT and heparin. A key aspect of

this structure is that thrombin is bound to a polymeric heparin sequence and therefore presents slightly
altered exosite 2 electrostatic surface features (not shown). Once again, the best 54 ‘affinity’ filtered
sequences from the more than 50,000 studied in the first stage were processed for the consistency of
binding test. Only four sequences were picked in this study (Figure 8B and Table 5). All the four
sequences bind with high consistency. In addition, the binding pose of these four sequences matches well
with that of heparin monomers (highly sulfated) observed in the crystal structure. The hydrogen bonding
analysis using LIGPLOT (Wallace et al. 1995) suggest that the sequences make favorable interactions
with key residues of exosite 2 including Arg93, Arg101, Arg126, Arg165, Arg233, Lys236 and Lys240.
Interestingly, all four hexasaccharide sequences identified by CVLS displayed a repeating disaccharide
unit of IdoAp – GlcNp with variations in sulfate position, which is essentially identical to the common
repeating disaccharide of heparin. Thus, this study also indicates that the common heparin sequence is
more favored to bind thrombin. Considering that these sequences are highly populated in unfractionated
heparin sample, the heparin – thrombin interaction turns out to be chemically non-specific, although
biologically, a distinct mode of binding in exosite 2 is preferred.
Significance
Our interest in designing and exploring the huge database of H/HS sequences arose from our
previous work (Raghuraman et al. 2006), where we used a limited hexasaccharide library (6859
sequences). Most docking approaches to date focus primarily on the affinity of interaction and minimally
on the specificity of interaction (Kitchen et al. 2004). Our genetic algorithm-based approach places major
emphasis on the specificity of interaction, which is more challenging to determine for H/HS. Our
approach allows screening of considerably large conformational space and attempts to reduce the number
of false positives.
This work represents the first, large scale combinatorial GAG library screening to date. Our work
demonstrates that such large library screening is feasible for GAG sequences, especially if a highresolution crystal structure of the target protein is available. Considering the success achieved for AT and
thrombin, two prototypic ‘highly specific’ and ‘non-specific’ GAG-binding proteins, respectively, we

expect that CVLS approach may be more generally applicable to other proteins, especially for other
serpins such as heparin cofactor II and protein C inhibitor, for which specificity features remain poorly
defined. Theoretically, the CVLS technology should be applicable to any GAG–protein system assuming
that appropriate validating solution experiments can be performed to assess predictions.
Our CVLS strategy utilized fairly stringent criteria for selection. While the affinity filter selected
the upper 0.1% of sequences, the specificity filter was set to select only those sequences that satisfy selfconsistency 100% of the time. It was possible to use high filtering stringency because the AT–H/HS
system is a biochemically well-studied system. For other less understood systems, such stringent criteria
may eliminate potentially useful information, which implies that appropriate relaxation in criteria may be
necessary to introduce. One important deduction from our work is that GAG docking onto proteins should
be approached with caution and care. We cannot assume that ‘one-size-fits-all’ approach typically used in
analyzing protein–ligand interactions will work well for GAG–protein studies as demonstrated by the
observation that a higher docking radius does not necessarily result in higher probability of an outcome.
This caution becomes even more important for relatively non-specific GAG–protein interactions for
which it becomes difficult to estimate the validity of a result.
This work also presents the first algorithm, the incremental neighborhood optimization strategy,
to design longer GAG sequences. This approach significantly reduces the computational cost and
enhances efficiency over de novo design of a longer GAG sequence. Yet, the approach is expected to
work for GAG–protein systems that exhibit high specificity. For non-specific system, it remains to be
seen whether the incremental strategy provides meaningful results.
Finally, we expect our CVLS technology to be especially useful in the design of pharmaceutically
useful agents. For example, the deduction of minimal ‘EF’ disaccharide sequence as the origin of
specificity implies that small GAG mimetics containing the EF domain should function as specific AT
activators. Such small GAG mimetics should be possible to design computationally.
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Figure Legends
Figure 1

A) Structure of natural pentasaccharide DEFGH, where D, E, F, G and H labels refer to
historical assignment of residue labels (Desai et al. 1998). Residue D forms the nonreducing end, while H is at the reducing end of the polysaccharide chain. Groups
highlighted in blue are critical for high-affinity interaction with antithrombin. R1, R2, R3
and R4 groups are variable groups. B) The UANRE library of oligosaccharides (di- to
octasaccharide) has a GlcAp or IdoAp residue at the non-reducing end and ends with a
GlcNp residue at the reducing end. C) The GlcNNRE library of oligosaccharides has a GlcNp
residue at the non-reducing end and either a GlcAp or IdoAp residue at the reducing end.
R1, R2, R3 and R4 variations, UAp epimerization variation and conformational variations
(1C4 or 2SO) for IdoAp residue generate 38 disaccharide building blocks.

Figure 2

Combinatorial virtual library screening (CVLS) protocol used to study the antithrombin
(AT) – heparin/heparan sulfate (H/HS) interaction. The CVLS protocol assessed the
interaction of two H/HS libraries (UANRE and GlcNNRE) using a dual filter strategy that
relied on the geometric convergence filter (RMSD) to assess specificity of binding.

Figure 3

Optimization of GOLD-based CVLS protocol for H/HS hexasaccharide sequences.
Parameters including docking radius (8 to 16 Å), number of GA runs (either 10 or 100) and
number of iterations (10,000 or 100,000; not shown here) were evaluated in a rigorous
manner for groups of H/HS hexasaccharide sequences including GDEF, GEFG, GFGH, GUSU,
and GSSS, which refer to 15 sequences containing the DEF structure, 15 sequences
containing the EFG structure, 15 sequences containing the FGH structure, 10 sequences
containing sub-optimal level of sulfation, and 10 sequence containing higher level of
sulfation, respectively. The structures of the 65 hexasaccharide sequences studied are listed
in Supplementary data, Table S1.

Figure 4

CVLS predicted hexasaccharide sequences from the GlcNNRE (A) and UANRE libraries (B)
containing 54,872 sequences each. Shown are overlays of the docked poses of
hexasaccharide sequences that bind AT with ‘high specificity’ by satisfying the dual filter
strategy. A) shows 24 sequences (blue sticks) from the GlcNNRE library and B) shows 24
sequences (blue sticks) from UANRE hexasaccharide library. Helices A (hA), D (hD) and P
(hP) of antithrombin are shown in ribbon form and residues Arg132, Arg129, Lys125 and
Arg114 are shown in ball and stick display. The crystal structure of DEFGH in green ball
and sticks display is shown to highlight correspondence with the CVLS predicted poses.

Figure 5

Optimization of docking radius to be used in CVLS of H/HS tetrasaccharide sequences. A
library of 17 DEF containing tetrasaccharides was assessed for ‘specificity’ of binding
using varying docking radius. See Supplementary data, Figure S1 for structural poses of the
specific tetrasaccharide sequences.

Figure 6

CVLS predicted disaccharide sequences from the UANRE (A) and GlcNNRE libraries (B).
Only 3 disaccharide sequences (blue sticks), each related to EF structure of pentasaccharide
DEFGH, were found to satisfy the dual filter strategy from the library of 78 UANRE
sequences (A). None of the 78 possible disaccharides (blue sticks) belonging to the
GlcNNRE library bound antithrombin with ‘high specificity’. Helices A (hA), D (hD) and P
(hP) of antithrombin are shown in ribbon form and residues Arg132, Arg129, Lys125 and
Arg114 are shown in ball and stick display. The crystal structure of DEFGH in green ball
and sticks display is shown to highlight correspondence with the CVLS predicted poses.

Figure 7

A) Incremental neighborhood optimization strategy used in the design of octasaccharide
sequences. Five hexasaccharide sequences that were found to be most optimal from each of
the two libraries (UANRE and GlcNNRE) were selected and then 38 disaccharide sequences of
UANRE and GlcNNRE libraries were appended at either the reducing or the non-reducing
ends. The total of 5384 = 760 octasaccharide sequences were then studied using the dual
filter CVLS protocol. B) Ten octasaccharide sequences from the GlcNNRE library and six
sequences from the UANRE library (not shown) satisfied the CVLS dual filter criteria.
Helices A (hA), D (hD) and P (hP) of antithrombin are shown in ribbon form and residues
Arg132, Arg129, Lys125 and Arg114 are shown in ball and stick display. The crystal
structure of DEFGH in green ball and sticks display is shown to highlight correspondence
with the CVLS predicted poses.

Figure 8

CVLS predicted hexasaccharide sequences that bind with a consistent mode onto exosite 2
of thrombin, Shown are overlays of the docked poses of sequences that . A) shows multiple
poses of the only sequence (blue sticks) that satisfied the dual filter CVLS strategy for
1XMN crystal structure of thrombin. B) shows multiple poses of the four sequences (blue
sticks) that satisfied the dual filter strategy for thrombin in the 1TB6 structure. Thrombin
surface and key exosite 2 residues are shown in ribbon and ball and stick representations,
respectively. The crystal structure of heparin bound in each of these structures is shown in
green sticks..

Table 1. Naming convention for the H/HS monosaccharides and the 38 disaccharide building blocks
derived from them.
Namea

Name

Conf.b

Anomer

Disaccharide Building Blocks

C4

α-

ZbB-YbCA

ua2A-YbC6A

ua2A-YbH3A

uaA

IdoAp

1

ua2A

IdoAp2S

1

C4

α-

ZbB-YbC6A

uc2A-YbC6A

uc2A-YbH3A

ucA

IdoAp

2

SO

α-

ZbB-Yb2A

uaA-Yb2A

ua2A-YbH36A

uc2A

IdoAp2S

2

α-

Zb2B-Yb2A

ua2A-Yb2A

uc2A-YbH36A

Yb2A

GlcNp2S

4

C1

α-

ZbB-Yb26A

uc2A-Yb2A

ucA-Yb2A

Yb23A

GlcNp2S3S

4

C1

α-

Zb2B-Yb26A

uaA-Yb26A

uc2A-Yb23A

Yb26A

GlcNp2S6S

4

C1

α-

ZbB-Yb23A

ucA-Yb26A

Yb236A

GlcNp2S3S6S

4

C1

α-

Zb2B-Yb23A

ua2A-Yb26A

Yb26A

GlcNp2S6S

4

C1

α-

ZbB-Yb236A

uc2A-Yb26A

YbCA

GlcNp2Ac

4

C1

α-

ZbB-YbHA

uaA-Yb23A

YbC6A

GlcNp2Ac6S

4

C1

α-

uaA-YbCA

ucA-Yb23A

YbHA

GlcNp

4

C1

α-

ucA-YbCA

ua2A-Yb23A

YbH3A

GlcNp3S

4

C1

α-

ua2A-YbCA

uaA-Yb236A

YbH36A

GlcNp3S6S

4

C1

α-

uc2A-YbCA

ucA-Yb236A

ZbB

GlcAp

4

C1

β-

uaA-YbC6A

ua2A-Yb236Ac

Zb2B

GlcAp2S

4

C1

β-

ucA-YbC6A

uc2A-Yb236Ac

SO

a

Symbols: Z = D-GlcAp, u = L-IdoAp, Y = D-GlcNp. Ring conformations: a = 1C4; b = 4C1; c = 2SO.

Substituents: H = No substitution at position 2; Ac = N-acetyl, S = sulfate; Anomer configuration: A = α,
B = β. bConformation. cDisaccharides modeled in addition to those presented by Esko and Selleck (2002)

Table 2. Average torsion across the 14 inter-glycosidic bonds used in this CVLS study.

Disaccharide Building Block

Φ
(O5-C1-O1-C4’)

Ψ
(C1-O1-C4’-C5’)

GlcAp(14)GlcNp

-81.8

-114.0

IdoAp(14)GlcNp

-87.7

-128.3

GlcNp(14)GlcAp

91.1

-151.6

GlcNp(14)IdoAp

87.4

-132.3

Table 3.

H/HS hexasaccharide sequences from two libraries of 54,872 sequences each that satisfied
the dual filter CVLS strategy for antithrombin.
#

Hexasaccharide Sequencea

UANRE Library
1
ZbB-Yb26A-ZbB-Yb236A-ucA-Yb2A
2
uc2A-Yb26A-ZbB-Yb236A-ucA-Yb2A
3
ucA-YbC6A-Zb2B-Yb23A-ucA-Yb2A
4
ua2A-YbH36A-ZbB-Yb236A-ucA-Yb2A
5
ucA-Yb26A-ZbB-Yb23A-ucA-YbCA
6
ucA-YbC6A-ZbB-Yb236A-ucA-Yb2A
7
ZbB-Yb26A-ZbB-Yb236A-ucA-YbCA
8
uaA-Yb23A-ZbB-Yb236A-ucA-Yb2A
9
ucA-Yb26A-ZbB-Yb236A-ucA-Yb2A
10
ua2A-Yb23A-ZbB-Yb236A-ucA-Yb236A
GlcNNRE Library
1
Yb23A-ua2A-Yb26A-Zb2B-Yb236A-ZbB
2
Yb26A-ua2A-Yb26A-ZbB-Yb236A-ZbB
3
Yb2A-ua2A-YbC6A-ZbB-Yb236A-ZbB
4
Yb23A-uaA-YbC6A-ZbB-Yb23A-ZbB
5
Yb2A-ua2A-Yb26A-Zb2B-Yb236A-ZbB
6
Yb26A-uaA-YbC6A-ZbB-Yb236A-ZbB
7
Yb26A-ua2A-Yb236A-ZbB-Yb236A-ZbB
8
Yb236A-ua2A-YbC6A-ZbB-Yb236A-ZbB
9
Yb2A-ua2A-Yb26A-Zb2B-Yb23A-ZbB
10
Yb26A-uaA-YbC6A-ZbB-Yb236A-uc2A
11
Yb2A-uaA-Yb26A-ZbB-Yb236A-ZbB
12
Yb26A-ua2A-Yb26A-Zb2B-Yb23A-ZbB
13
Yb2A-uaA-Yb236A-ZbB-Yb236A-uc2A
14
Yb26A-ua2A-Yb26A-ZbB-Yb23A-ZbB
15
Yb23A-ua2A-YbC6A-ZbB-Yb236A-uc2A
16
Yb236A-ua2A-YbC6A-ZbB-Yb23A-ZbB
17
Yb2A-ua2A-Yb26A-ZbB-Yb236A-ZbB
18
Yb26A-uaA-YbC6A-ZbB-Yb23A-uc2A
19
Yb236A-ua2A-Yb236A-ZbB-Yb236A-ZbB
20
Yb23A-uc2A-Yb26A-Zb2B-Yb236A-ZbB
21
YbC6A-ZbB-Yb236A-ucA-Yb2A-ua2A
22
Yb23A-uaA-YbC6A-ZbB-Yb23A-uc2A
23
Yb23A-ua2A-Yb236A-ZbB-Yb236A-ZbB
24
Yb236A-ua2A-Yb26A-Zb2B-Yb236A-uc2A
a

GoldScoreb

# of H-bondsc

137.81
136.76
133.15
132.83
132.66
132.42
132.39
131.63
131.25
129.54

13
13
14
12
14
14
12
12
14
14

147.76
142.34
141.45
139.57
138.59
138.57
136.99
135.44
134.74
134.55
134.3
134.23
133.72
133.08
132.82
132.60
132.54
132.43
131.50
131.21
130.78
130.29
129.75
129.06

12
11
11
14
14
10
10
11
10
13
12
12
11
12
11
10
12
11
13
13
16
9
11
13

See definitions of residue labels and substitution in Table 1. bRefers to modified GoldScore, as defined in
the Methods section. cNumber of hydrogen bonds calculated using LIGPLOT.

Table 4. H/HS octasaccharide sequences that satisfied the CVLS strategy for antithrombin.
#

Octasaccharide Sequencea

GoldScoreb

# of H-bondsc

UANRE Library
1
Zb2B-Yb2A-ZbB-Yb26A-ZbB-Yb236A-ucA-Yb2A
145.53
16
2
ucA-Yb26A-uc2A-Yb26A-ZbB-Yb236A-ucA-Yb2A
137.10
13
3
uc2A-Yb26A-uc2A-Yb26A-ZbB-Yb236A-ucA136.19
14
4
uaA-Yb236A-uc2A-Yb26A-ZbB-Yb236A-ucA134.42
14
Yb2A
5
uaA-Yb2A-uc2A-Yb26A-ZbB-Yb236A-ucA-Yb2A
131.93
13
Yb2A
6
uc2A-YbH3A-uc2A-Yb26A-ZbB-Yb236A-ucA130.27
12
GlcNNREYb2A
Library
1
Yb2A-ua2A-Yb26A-Zb2B-Yb236A-ZbB-Yb26A149.99
13
2
Yb23A-ua2A-Yb26A-Zb2B-Yb236A-ZbB-YbH3A149.62
13
Zb2B
3
Yb23A-ua2A-Yb26A-Zb2B-Yb236A-ZbB-YbCA148.30
10
ua2A
4
Yb23A-ua2A-Yb26A-Zb2B-Yb236A-ZbB-Yb26A147.56
14
uaA
5
Yb23A-ua2A-Yb26A-Zb2B-Yb236A-ZbB-Yb23A146.40
13
ua2A
6
Yb2A-ua2A-YbC6A-ZbB-Yb236A-ZbB-Yb236A146.09
15
uc2A
7
Yb2A-ua2A-Yb26A-Zb2B-Yb236A-ZbB-Yb236A141.69
11
ZbB
8
Yb23A-ua2A-Yb26A-Zb2B-Yb236A-ZbB-Yb23A141.67
12
ua2A
9
Yb23A-ua2A-Yb26A-Zb2B-Yb236A-ZbB-YbCA138.82
11
ZbB
10
Yb2A-ua2A-YbC6A-ZbB-Yb236A-ZbB-Yb26A136.58
9
ZbB
ua2A
a
See definitions of residue labels and substitution in Table 1. bRefers to modified GoldScore, as defined in
the Methods section. cNumber of hydrogen bonds calculated using LIGPLOT.

Table 5. H/HS hexasaccharide sequences that satisfied the CVLS strategy for thrombin..
#
1XMN
1
1TB6
1
2
3
4
a

GoldScoreb

# of H-bondsc

ua2A-Yb26A-uc2A-Yb2A-uaA-Yb236A

121.48

14

ua2A-Yb23A-uc2A-YbC6A-ua2A-Yb26A
ua2A-Yb26A-ucA-Yb23A-ua2A-Yb26A
ua2A-YbC6A-uc2A-YbC6A-ua2A-YbH36A
ua2A-YbCA-uc2A-Yb26A-ua2A-YbH36A

136.13
130.38
129.36
128.91

13
13
12
14

Hexasaccharide Sequencea

See definitions of residue labels and substitution in Table 1. bRefers to modified GoldScore, as defined in
the Methods section. cNumber of hydrogen bonds calculated using LIGPLOT.
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